Wesley Kanne Clark's most recent trade in ImmunityBio Inc was a trade of 77,633 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
ImmunityBio Inc | Wesley Kanne Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 77,633 | 77,633 | - | - | Stock Option (right to buy) | |
ImmunityBio Inc | Wesley Kanne Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 158,263 | 158,263 | - | - | Stock Option (right to buy) | |
ImmunityBio Inc | Wesley Kanne Clark | Director | Purchase of securities on an exchange or from another person at price $ 2.91 per share. | 01 Jun 2023 | 7,000 | 8,000 | - | 2.9 | 20,370 | Common Stock |
ImmunityBio Inc | Wesley Kanne Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 167,937 | 167,937 | - | - | Stock Option (right to buy) | |
ImmunityBio Inc | Wesley Kanne Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 26,064 | 26,064 | - | - | Stock Option (right to buy) | |
ImmunityBio Inc | Wesley Kanne Clark | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 21,873 | 21,873 | - | - | Stock Option (right to buy) |